Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
No additional AE; HCP called to report inadvertent administration of ROTATEQ and VAXELIS after a temperature excursion that occurred on 07MAY2025. ROTATEQ and VAXELIS were administered to a patient on 28MAY2025.; This spontaneous report was received from a Nurse and refers to a 2-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 28-May-2025, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) administered as prophylaxis (strength, Lot No, expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided), also with an improperly stored dose of diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus (VAXELIS) (indication, strength, Lot No, expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); after a temperature excursion of 1.4 degree Celsius (C) during a time frame of 18 minutes that occurred (on 07-May-2025) (product storage error). No previous temperature excursions were reported. No additional adverse events or PQC were provided (no adverse event).